RE:RE:Revenue surpriseInvestor10X wrote: tankumo wrote: I would not count out the surprised upside revenue on AI and telehealth, MG seems to be capable of delivering result.
Look at the covid revenue, I thought Kai medical lab would be good business but our covid business is bigger than CBDT.
So I would not be surprised if our telehealth sector can score big, and AI too, if we can land big contracts I would not be surprised.
JMHO.
MG did mention that they are in talks with some German companies for some very large AI contracts, but if contracts are signed, he did not expect any contract to be signed until the end of this year or into next year. He cautioned that contracts of this size take time.
By the end of this year DM could be sitting on $30- $40 million in their bank account with revenues around $60 -$70 million. When you have that amount of money backing the company it gives confidence to clients that you can hire the people you need to improve, grow or expand the company. A lot of problems can be solved with $30 - $40 million in the bank.
I would caution against an expectation of a $30M cash position. At best I would be looking for $20M. The third quarter may be very soft, possibly break even or a small loss. The fourth quarter will see sales roaring back, but we won't have those figures until April 2022.